MADISON BREANNE HAYES PA-C
Prescription History 1629629902
Physician Assistant in Tulsa, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MADISON BREANNE HAYES PA-C, an active Physician Assistant specialist practicing in Tulsa, OK. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 39 documented patient claims. Among these therapy options, the most frequently utilized medication is Buspirone Hcl, which accounts for 16 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Buspirone Hcl | 16 | $13.40▼ below OK avg | ▼ Less than typical |
About Buspirone Hcl: This medication is used to treat anxiety. Show more ▾ It may help you think more clearly, relax, worry less, and take part in everyday life. It may also help you to feel less jittery and irritable, and may control symptoms such as trouble sleeping, sweating, and pounding heartbeat. Buspirone is a medication for anxiety (anxiolytic) that works by affecting certain natural substances in the brain (neurotransmitters). An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM. In 2024, this provider wrote 16 Medicare prescriptions for Buspirone Hcl, about a third of the volume of the typical Oklahoma prescriber of this medication (49.8). Medicare paid an average of $13.40 per fill, versus $15.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Fluoxetine Hcl | 12 | $0.90▼ below OK avg | ▼ Less than typical |
About Fluoxetine Hcl: This medication is used to treat certain mental/mood disorders (such as depression, panic attacks, obsessive compulsive disorder). Show more ▾ It is also used to treat a certain eating disorder (bulimia) and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). Fluoxetine belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. In 2024, this provider wrote 12 Medicare prescriptions for Fluoxetine Hcl, about a third of the volume of the typical Oklahoma prescriber of this medication (42.3). Medicare paid an average of $0.90 per fill, versus $11.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Quetiapine Fumarate | 11 | $17.18▼ below OK avg | ▼ Less than typical |
About Quetiapine Fumarate: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Show more ▾ Quetiapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER. In 2024, this provider wrote 11 Medicare prescriptions for Quetiapine Fumarate, about a quarter of the volume of the typical Oklahoma prescriber of this medication (50.4). Medicare paid an average of $17.18 per fill, versus $18.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MADISON BREANNE HAYES PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Tulsa, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
